ArticleJournal of investigative medicine high impact case reports
Guillain-Barré Syndrome as an Initial Manifestation of Systemic Lupus Erythematous: Rare Case Report.
Article in Journal of investigative medicine high impact case reports. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disorder characterized by a wide spectrum of clinical features ranging from skin and joint involvement to organ dysfunction, including the central nervous system, peripheral nervous system (PNS), and renal failure. Guillain-Barré syndrome (GBS) is an immune-mediated acute polyradiculoneuropathy involving the PNS and represents an unusual initial manifestation of SLE. An 18-year-old female presented with subacute, progressive, ascending weakness of the lower and upper limbs, accompanied by hyporeflexia. Further clinical and laboratory evaluation revealed that the patient fulfilled the diagnostic criteria for SLE. Electromyography and nerve conduction studies demonstrated normal conduction velocities and latencies, but there was a reduced amplitude of compound motor action potentials in the distal muscles of the upper and lower limbs, without conduction block. Needle electromyography findings were consistent with a diagnosis of acute motor axonal neuropathy, considered a moderate-to-severe form of GBS. On evaluation, the patient exhibited polyarthralgia, widespread generalized erythematous rash, microcytic anemia, and bilateral pleural effusion. Immunological profiling revealed high-titer antinuclear antibody (1:1280), elevated anti-dsDNA (171 IU/mL), positive anti-Sm antibodies, and low C3/C4 levels. Treatment with pulse steroids (methylprednisolone 1 g/day for 3 days), immunosuppressants, and intravenous immunoglobulin led to marked improvement. This case emphasizes that SLE can precipitate GBS, and early recognition of this overlap may influence therapeutic strategies and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.